Anthrax Vaccine Adsorbed (AVA)
GPTKB entity
Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:mythological_figure
|
| gptkbp:antagonist |
aluminum hydroxide
|
| gptkbp:appointed_by |
injection
|
| gptkbp:approves |
gptkb:1970
gptkb:U._S._Food_and_Drug_Administration |
| gptkbp:clinical_trial |
gptkb:military_officer
veterinarians first responders conducted for safety and efficacy laboratory workers animal handlers |
| gptkbp:collaborated_with |
antibiotics for post-exposure
|
| gptkbp:contraindication |
severe allergic reaction to vaccine components
|
| gptkbp:developed_by |
gptkb:military_unit
|
| gptkbp:dosage_form |
gptkb:item
every 6 to 12 months |
| https://www.w3.org/2000/01/rdf-schema#label |
Anthrax Vaccine Adsorbed (AVA)
|
| gptkbp:is_used_for |
prevention of anthrax
|
| gptkbp:is_vulnerable_to |
inactivated vaccine
ongoing studies for long-term immunity adverse event reporting system 3 doses at 0, 7, and 21 or 28 days approximately 93% after 3 doses by trained healthcare professionals increased with booster doses studies on alternative dosing schedules studies on combination with other vaccines studies on effectiveness in older adults studies on long-term side effects. studies on safety in children studies on safety in pregnant women studies on immune response in different populations studies on immune response in immunocompromised individuals |
| gptkbp:manager |
intramuscular
|
| gptkbp:manufacturer |
gptkb:Emergent_Bio_Solutions
|
| gptkbp:produced_by |
gptkb:U._S._government
|
| gptkbp:shelf_life |
up to 24 months
|
| gptkbp:side_effect |
fatigue
headache muscle pain nausea rash joint pain mild fever local reactions rare serious allergic reactions systemic reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:suitable_for |
high-risk individuals
general public without risk |
| gptkbp:targets |
gptkb:Bacillus_anthracis
|
| gptkbp:traded_on |
gptkb:Bio_Thrax
|
| gptkbp:treatment |
not effective alone
|
| gptkbp:used_in |
biodefense programs
|